# A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease

> **NCT06557850** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **H. Lundbeck A/S** · enrollment: 20 (actual)

## Conditions studied

- Thyroid Eye Disease

## Interventions

- **DRUG:** Lu AG22515

## Key facts

- **NCT ID:** NCT06557850
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-09-19
- **Primary completion:** 2026-03-17
- **Final completion:** 2026-09-29
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06557850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06557850, "A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06557850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*